N@N

Finkelstein Thompson LLP Announces Investigation of Microfluidics International Corporation

_{//science-technology.news-articles.net/content/2 .. -of-microfluidics-international-corporation.html}
^{Published in Science and Technology on Thursday, January 13th 2011 at 14:46 GMT by Market Wire}  

WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Microfluidics International Corporation (aMicrofluidicsa or the aCompanya) (OTC: MFLU) concerning the proposed acquisition of the Company by IDEX Corporation. Under the terms of the offer, Microfluidics shareholders will receive $1.35 in cash for each share of the Company's common stock.

The investigation is focused on the potential unfairness of the deal price to Microfluidics shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among Microfluidics Board members. In particular, according to Yahoo! Finance, at least one analyst has set a target price of $2.00 for Microfluidics shares.

If you are interested in discussing your rights as a Microfluidics shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.